Skip to content
Home/Companies/MedTech/R3 Vascular
R3 Vascular

R3 Vascular

MedTech·United States·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns R3 Vascular?

R3 Vascular is currently owned by 415 Capital Management through 415 Capital Fund I (2020 vintage), since 2020.

Hand-verified · updated 2026-08-10

415 Capital Management
Investor
415 Capital Management
415 Capital Fund I · 2020 · VC

Key facts

HQUnited States
SectorMedTech
StatusActive
Websitewww.r3vascular.com

More from 415 Capital Fund I

Other portfolio companies in the same fund.

Laza Medical
Laza Medical
Active
MedTechUnited States· 2023
Distalmotion
Active
MedTechSwitzerland· 2022
TRiCares
TRiCares
Active
MedTechGermany· 2022
Cardiac Success
Cardiac Success
Active
MedTechIsrael· 2021
Hilo
Hilo
Active
MedTechSwitzerland· 2021
Supira Medical
Supira Medical
Active
MedTechUnited States· 2020

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Optos
Exited 2015
Amadeus Capital PartnersUK
to
Axomove
Axomove
Active
Go CapitalFrance· 2026
Bioliberty
Active
Scottish National Investment BankUK· 2026
CertHub
Active
Cusp Capital PartnersGermany· 2026
Clee Medical
Clee Medical
Active
High-Tech Gruenderfonds (HTGF)Switzerland· 2026
CollimateHealth
Active
Caesar Ventures ManagementGermany· 2026
Track R3 Vascular

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on R3 Vascular.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue